Avalglucosidase alfa-ngpt

Nexviazyme (avalglucosidase alfa-ngpt) is an enzyme replacement therapy used to treat Pompe disease, a rare genetic disorder causing muscle weakness. It's administered intravenously as a powder for solution, with each vial containing 100 mg of the active ingredient. Manufactured by Genzyme Corporation, it's approved for prescription use. This information was generated using AI and is provided for informational and research purposes only.